Sun Pharmaceutical Industries informs about update

27 May 2023 Evaluate

In connection with its earnings call held on May 26, 2023, Sun Pharmaceutical Industries has informed that Global Ilumya sales for FY23 were US$ 477 million, up by about 51% as compared to FY22.

The above information is a part of company’s filings submitted to BSE.

Sun Pharma Inds. Share Price

1620.80 -52.75 (-3.15%)
20-Jan-2026 14:05 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1620.80
Dr. Reddys Lab 1175.85
Cipla 1380.80
Zydus Lifesciences 876.90
Lupin 2174.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×